As SLIT2 has been shown to inhibit cell migration of colorectal cancer cells [44], we wanted to analyze whether supplementing ddR1 + R2 cell cultures with SLIT2 recombinant protein would affect the enhanced mobility of the ddR1 + R2 cells. The gene discussed is SLIT2; the disease is colorectal cancer.